|
|
||||||||
The Journal of Immunology, Vol 151, Issue 10 5822-5839, Copyright © 1993 by American Association of Immunologists
ARTICLES |
M Sasano, DR Burton and GJ Silverman
Sam and Rose Stein Institute for Research on Aging, University of California, San Diego, La Jolla 92093.
Unconventional Ag for B cells that are comparable to known superantigens for T lymphocytes have not been well characterized. However, the bacterial membrane protein, Staphylococcal protein A (SpA), has sites that interact with the Fab of many IgM, IgA, IgG, and IgE, and in recent reports we have provided evidence of VH restriction in Fab that bind SpA. To investigate the molecular basis for this Fab binding specificity, we have selected monoclonal Fab from a phage- display combinatorial Ig library, based on the ability to bind SpA. By this approach, in an unselected human polyclonal IgG Fab library, about 17% of antibody-expressing clones were found to bind SpA. SpA binding was completely restricted to Fab with VH3 H chains, and about 60% of VH3 Fab in the unselected library had SpA binding capacity. Analysis of 21 VH sequences and 6 VL sequences demonstrated that Fab that bind SpA use diverse VH3 genes, while the L chains derive from a variety of V kappa and V lambda gene families. By creation of antibodies with differential H-L chain pairing, the global capacity to bind SpA was shown to be dictated by VH3 usage, but different L chain usage could result in up to a fourfold change in binding affinity. The apparent KD of the SpA binding by different Fab ranged from 2.5 x 10(-7) to > 10(- 5) M. Furthermore, repeated rounds of in vitro panning selected for antibodies based on higher binding affinity. These data indicate that the pattern of VH family restriction of Ig reactive with SpA is comparable to known superantigens, and there is a hierarchy within the binding affinities of VH3 Fab based on V gene usage.
This article has been cited by other articles:
![]() |
C. S. Goodyear, M. Narita, and G. J. Silverman In Vivo VL-Targeted Activation-Induced Apoptotic Supraclonal Deletion by a Microbial B Cell Toxin J. Immunol., March 1, 2004; 172(5): 2870 - 2877. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, S. Pereira, P. Van Belle, P. Tsui, D. Elder, D. Speicher, K. Deen, A. Linnenbach, R. Somasundaram, R. Swoboda, et al. Isolation of the Melanoma-Associated Antigen p23 Using Antibody Phage Display J. Immunol., January 1, 2001; 166(1): 432 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Silverman, S. P. Cary, D. C. Dwyer, L. Luo, R. Wagenknecht, and V. E. Curtiss A B Cell Superantigen-induced Persistent "Hole" in the B-1 Repertoire J. Exp. Med., July 3, 2000; 192(1): 87 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Scamurra, D. J. Miller, L. Dahl, M. Abrahamsen, V. Kapur, S. M. Wahl, E. C. B. Milner, and E. N. Janoff Impact of HIV-1 Infection on VH3 Gene Repertoire of Naive Human B Cells J. Immunol., May 15, 2000; 164(10): 5482 - 5491. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Graille, E. A. Stura, A. L. Corper, B. J. Sutton, M. J. Taussig, J.-B. Charbonnier, and G. J. Silverman Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: Structural basis for recognition of B-cell receptors and superantigen activity PNAS, May 9, 2000; 97(10): 5399 - 5404. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Cary, J. Lee, R. Wagenknecht, and G. J. Silverman Characterization of Superantigen-Induced Clonal Deletion with a Novel Clan III-Restricted Avian Monoclonal Antibody: Exploiting Evolutionary Distance to Create Antibodies Specific for a Conserved VH Region Surface J. Immunol., May 1, 2000; 164(9): 4730 - 4741. [Abstract] [Full Text] [PDF] |
||||
![]() |
J E McElveen, P B Furtado, S J Smith, M R Clark, I Spendlove, H F Sewell, and F Shakib Characterisation of a mouse monoclonal anti-idiotype reactive with a V region sequence commonly used by human immunoglobulins Mol. Pathol., April 1, 2000; 53(2): 77 - 82. [Abstract] [Full Text] |
||||
![]() |
M. Leonetti, J. Galon, R. Thai, C. Sautes-Fridman, G. Moine, and A. Menez Presentation of Antigen in Immune Complexes Is Boosted by Soluble Bacterial Immunoglobulin Binding Proteins J. Exp. Med., April 19, 1999; 189(8): 1217 - 1228. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Karray, L. Juompan, R. C. Maroun, D. Isenberg, G. J. Silverman, and M. Zouali Structural Basis of the gp120 Superantigen-Binding Site on Human Immunoglobulins J. Immunol., December 15, 1998; 161(12): 6681 - 6688. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Silverman, J. V. Nayak, K. Warnatz, F. F. Hajjar, S. Cary, H. Tighe, and V. E. Curtiss The Dual Phases of the Response to Neonatal Exposure to a VH Family-Restricted Staphylococcal B Cell Superantigen J. Immunol., November 15, 1998; 161(10): 5720 - 5732. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Domiati-Saad and P. E. Lipsky Staphylococcal Enterotoxin A Induces Survival of VH3-Expressing Human B Cells by Binding to the VH Region with Low Affinity J. Immunol., August 1, 1998; 161(3): 1257 - 1266. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Kozlowski, W. Li, M. Goldschmidt, and A. I. Levinson In Vivo Inflammatory Response to a Prototypic B Cell Superantigen: Elicitation of an Arthus Reaction by Staphylococcal Protein A J. Immunol., June 1, 1998; 160(11): 5246 - 5252. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhong and L.-a. Pirofski Antifungal Activity of a Human Antiglucuronoxylomannan Antibody Clin. Vaccine Immunol., January 1, 1998; 5(1): 58 - 64. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |